SS-31: Mechanism of Action in Research Models

The SS-31 mechanism of action centers on delivering a small peptide to one place: the inner mitochondrial membrane. SS-31 is also known as Elamipretide or MTP-131. It is a synthetic tetrapeptide from the Szeto-Schiller series. It is aromatic-cationic, meaning it mixes ring-shaped and positively charged amino acids. This overview sums up how the peptide is tested in biochemical assays, cell culture, and animal models. Read it strictly in a research context.

Its documented specs are:

• Sequence: D-Arg-Dmt-Lys-Phe-NH2
• Molecular formula: C32H49N9O5
• Molecular weight: about 639.80 g/mol

What is the SS-31 mechanism of action?

SS-31 is studied as a probe that gathers at the inner mitochondrial membrane and binds cardiolipin. Its design drives that behavior. Aromatic and basic amino acids alternate along the chain. This gives the molecule a net positive charge.

Three features also make it harder for enzymes to break down:

• The non-natural amino acid 2',6'-dimethyltyrosine, or Dmt
• The amide cap at the C-terminal end
• The D-form arginine

Labs use SS-31 to study how peptide chemistry alone can steer a molecule to one organelle.

Because it reaches one specific part of the cell, SS-31 is seen as a clean tool for mitochondria-focused questions. That places it next to other longevity and energy reagents. One is the coenzyme in the NAD+ mechanism and biochemical role overview. NAD+ supplies the reducing power that mitochondria rely on to make energy.

What is the structural basis of SS-31?

The sequence D-Arg-Dmt-Lys-Phe-NH2 packs several deliberate design choices into four amino acids. The aromatic ones (Dmt, Phe) alternate with the basic ones (Arg, Lys). This spreads a net positive charge across an amphipathic surface. Amphipathic means one face is drawn to water and the other to fat.

The literature describes three features that make peptidases, or peptide-cutting enzymes, less able to cleave it. They are the Dmt residue, the C-terminal amide, and the D-form arginine. This keeps the peptide intact for longer in lab batches.

Labs see these features as the reason the molecule acts as a stable, reliable probe. It does not behave like a fragment that breaks down fast. Its amphipathic, positive character is also the trait most tied to how it moves toward the inner membrane. This links structure to targeting in a way that labs can test one amino acid at a time.

How does SS-31 target mitochondria and bind cardiolipin?

SS-31's uptake into mitochondria is reported to need neither energy nor membrane potential. It is reported to gather at the inner membrane at levels far above those in the surrounding cytosol. Many targeting methods depend on membrane potential. This route is studied as a way to reach damaged or depolarized mitochondria, where potential-based uptake would fail.

At the inner membrane, SS-31 is reported to bind cardiolipin. Cardiolipin is a phospholipid that is concentrated there. In lab systems, this binding is studied for its effect on:

• The shape of the cristae, the folds of the inner membrane.
• How the electron transport chain is organized, since cardiolipin helps build respiratory supercomplexes.
• How well the mitochondrial membrane holds together under stress.

This idea of targeting a lipid rather than a receptor underlies most SS-31 study designs. It also sets SS-31 apart from receptor-directed peptides in the same category.

How does SS-31 relate to oxidative stress and bioenergetics?

In research, SS-31 is studied for reported effects on mitochondrial reactive oxygen species, or ROS. It is also studied for effects on how efficiently mitochondria make ATP. Labs use cell culture and isolated mitochondria assays. They measure membrane potential, ATP-related readouts, and oxidative stress markers under controlled conditions.

Labs test a chain of linked steps:

1. SS-31 binds cardiolipin.
2. This shapes how the inner membrane is organized.
3. That affects how well the electron transport chain works.
4. That shifts the balance between useful respiration and ROS leakage.

Each step is measured with its own assay. This way, a change at the membrane can be tied to a change in energy output, not just assumed.

These oxidative stress endpoints link SS-31 to wider redox biology. Teams studying antioxidant defense often study it next to the thiol tripeptide in the glutathione mechanism of action overview. Glutathione buffers reactive species through a different chemical route. The two are complementary probes of how cells manage oxidative load.

Why does the cardiolipin target matter?

Cardiolipin sits at the structural heart of mitochondrial energy production. So a molecule that binds it gives labs a clear handle on how the inner membrane is organized.

In damaged mitochondria, cardiolipin is reported to be prone to peroxidation and remodeling. Peroxidation is damage from oxidation. A probe that binds cardiolipin lets labs ask how a stable lipid setting relates to preserved respiration. This idea anchors SS-31 study designs. It also sets SS-31 apart from mitochondrial dyes and carriers that depend on membrane potential.

How does SS-31 compare with other bioenergetic tools?

SS-31 is rarely studied alone. Respiration depends on cofactor supply and redox balance. So comparison panels often include metabolic reagents such as the NAD+ precursor family and thiol antioxidants.

Labs contrast a structural probe aimed at the membrane with a free-moving cofactor or antioxidant. This helps them tell whether a change comes from inner-membrane organization or from general metabolic supply. It sharpens the reading of any single result.

Why is membrane-potential independence a study variable?

SS-31 uptake is reported not to depend on mitochondrial membrane potential, and labs return to this trait often. Many classic mitochondrial probes and carriers build up in line with inner-membrane potential. So they fail in depolarized, damaged mitochondria. Those are often the mitochondria of most research interest. A route that does not need potential is studied as a way around this limit. It lets the peptide reach damaged organelles.

Because of this trait, labs use SS-31 to ask a clear question. Can the peptide stay bound to the inner membrane under stress that collapses membrane potential? Study designs often pair potential measurements with location readouts. This lets labs watch uptake and organelle state together. That is how the claim is tested within a given model, not assumed.

How should mechanistic data on SS-31 be read?

Current knowledge comes from in vitro assays, isolated mitochondria, and animal models. Read findings as observations within their test setting, not as settled effects in the body. The reported cardiolipin binding and energy effects remain research descriptions tied to specific model systems.

Labs planning studies can review model-specific uses in the SS-31 research applications overview. Preparation practice is in the SS-31 handling and reconstitution guide. The peptide is listed at 99 percent or greater purity, with a third-party-verified certificate of analysis, on the SS-31 product page.

For research use only. SS-31 is an investigational research peptide and is not approved for human or veterinary use. All descriptions refer to preclinical and in vitro laboratory research.